Effects of Testosterone Undecanoate as a Male Contraceptive Candidate on Rat Immunological Features

Immunopharmacology and Immunotoxicology

Volumn 25, Issue 4, 2003, Pages 627-643

  Yu, Mingcan ^a,b   Cao, Xiaomei ^a   Xu, Jinju ^a   Wang, Xiaolei ^a   Yang, Jing ^a   Wang, Xinghai ^c   Ben, Kunlong ^a,b  

^a KUNMING INSTITUTE OF ZOOLOGY   (China)

^b UNIVERSITY OF CHINESE ACADEMY OF SCIENCES   (China)

^c Jiangsu Family Planning Institute   (China)

Author keywords

Epithelium thickness; Immunological parameters; Male contraceptive; Rats; Secretory component; Testosterone undecanoate

Indexed keywords

COMPLEMENT; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; TESTOSTERONE UNDECANOATE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIBODY DETECTION; ARTICLE; B LYMPHOCYTE; CELL VIABILITY; CHRONOPHARMACOLOGY; COMPLEMENT SYSTEM; CONTRACEPTION; CONTROLLED STUDY; DRUG EFFECT; DRUG SAFETY; GENITAL SYSTEM; HORMONE ACTION; IMMUNE RESPONSE; IMMUNOGLOBULIN BLOOD LEVEL; INJECTION; LEUKOCYTE COUNT; LYMPHOCYTE COUNT; LYMPHOCYTE PROLIFERATION; MALE; NATURAL KILLER CELL; NONHUMAN; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; SPERMATOZOON COUNT; SPLEEN CELL; T LYMPHOCYTE; THICKNESS; URETHRA;

ANIMALS; COMPLEMENT SYSTEM PROTEINS; CONTRACEPTIVE AGENTS, MALE; FEMALE; GENITALIA, MALE; HUMANS; IMMUNITY; IMMUNOGLOBULINS; LEUKOCYTE COUNT; LYMPHOCYTE ACTIVATION; LYMPHOCYTE SUBSETS; MALE; RATS; RATS, SPRAGUE-DAWLEY; REPRODUCTION; SAFETY; SPERM COUNT; TESTOSTERONE; TIME FACTORS; URETHRA;

ANIMALIA;

EID: 0344304599     PISSN: 08923973     EISSN: None     Source Type: Journal    
DOI: 10.1081/IPH-120026446     Document Type: Article

References (30)

1. Zhang, G.Y.; Gu, Y.Q.; Wang, X.H.; Cui, Y.G.; Bremner, W.J. A clinical trial of injectable testosterone undecanoate as a potential male contraceptive in normal Chinese men. J. Clin. Endocrinol. Metab. 1999, 84 (10), 3642-3647.
2. Kamischke, A.; Plöger, D.; Venherm, S.; von Eckardstein, S.; von Eckardstein, A.; Nieschlag, E. Intramuscular testosterone undecanoate with or without oral levonorgestrel: a randomized placebo-controlled feasibility study for male contraception. Clin. Endocrinol. 2000, 53 (1), 43-52.
3. Kamischke, A.; Venherm, S.; Plöger, D.; von Eckardstein, S.; Nieschlag, E. Intramuscular testosterone undecanoate and norethisterone enanthate in a clinical trial for male contraception. J. Clin. Endocrinol. Metab. 2001, 86 (1), 303-309.
4. Wen, X.H.; Wang, X.H.; Tong, J.S.; Yang, Z.W.; Zhang, G.Y. Reversible effect of testosterone undecanoate injection on spermatogenesis in rats. Asian J. Androl. 2000, 2 (3), 207-211.
5. Zhang, G.Y.; Gu, Y.Q.; Wang, X.H.; Cui, Y.G.; Bremner, W.J. A pharmacokinetic study of injectable testosterone undecanoate in hypogonadal men. J. Androl. 1998, 19 (6), 761-768.
6. Gu, Y.Q.; Zhang, G.Y. Androgens alone for hormonal male contraception. In Male Contraception; Qian, S.Z., Handelsman, D.J., Waites, G.M.H., Eds.; First Asia-Pacific Forum on Andrology, Shanghai, China, Oct 17-21, 2002; Asian J. Androl. 2002, 4(3), 32.
7. Gu, Y.Q.; Zhang, G.Y. Androgens alone for hormonal male contraception. In Male Contraception; Qian, S.Z., Handelsman, D.J., Waites, G.M.H., Eds.; First Asia-Pacific Forum on Andrology, Shanghai, China, Oct 17-21, 2002; Asian J. Androl. 2002, 4(3), 32.
8. Meriggiola, M.C.; Costantino, A.; Cerpolini, S. Recent advances in hormonal male contraception. Contraception 2002, 65 (4), 269-272.
9. Marx, P.A.; Spira, A.I.; Gettie, A.; Dailey, P.J.; Veazey, R.S.; Lackner, A.A.; Mahoney, C.J.; Miller, C.J.; Claypool, L.E.; Ho, D.D.; Alexander, N.J. Progesterone implants enhance SIV vaginal transmission and early viral load. Nat. Med. 1996, 2 (10), 1084-1089.
10. Mostad, S.B.; Overbaugh, J.; Devange, D.M.; Welch, M.J.; Chohan, B.; Mandaliya, K.; Nyange, P.; Martin, H.L. Jr.; Ndinya-Achola, J.; Bwayo, J.J.; Kreiss, J.K. Hormonal contraception, vitamin A deficiency, and other risk factor for shedding of HIV-1 infected cells from cervix and vagina. Lancet 1997, 350 (9082), 922-927.
11. Cates, W. Jr. Contraception, contraceptive technology, and STDs. In Sexually Transmitted Diseases, 3rd Ed.; Holmes, K.K., Mardh, P.-A., Sparling, P.F., Lemon, S.M., Stamm, W.E., Piot, P., Wasserheit, J.N., Eds.; McGraw-Hill Companies: New York, NY, 1999; 1067-1076.
12. Kaushic, C.; Zhou, F.; Murdin, A.D.; Wira, C.R. Effects of estradiol and progesterone on susceptibility and early immune responses to Chlamydia trachomatis infection in the female reproductive tract. Infect. Immun. 2000, 68 (7), 4207-4216.
13. Stern, J.E.; Gardner, S.; Quirk, D.; Wira, C.R. Secretory immune system of the male reproductive tract: effects of dihydrotestosterone and estradiol on IgA and secretory component levels. J. Reprod. Immunol. 1992, 22 (1), 73-85.
14. Olsen, N.J.; Kovacs, W.J. Effects of androgens on T and B lymphocyte development. Immunol. Res. 2001, 23 (2/3), 281-288.
15. Wang, Y.; Ben, K.; Cao, X.; Wang, Y. Transport of anti-sperm monoclonal IgA and IgG into murine male and female genital tracts from blood: effect of sex hormones. J. Immunol. 1996, 156 (3), 1014-1019.
16. Wang, X.; Zhao, X.; Ben, K.; Cao, X.; Wang, Y.; Zhou, H. Circulating IgA- and IgG-secreting hybridoma cells in peripheral blood preferably migrate to female genital tracts. The role of sex hormones. Immunology 2002, 106 (3), 343-353.
17. Kanda, N.; Tsuchida, T.; Tamaki, K. Testosterone inhibits immunoglobulin production by human peripheral blood mononuclear cells. Clin. Exp. Immunol. 1996,106 (2), 410-415.
18. Cao, X.; Ben, K.; Wang, Y.; Wang, Y. Effects of γ-aminobutyric acid, progesterone and ionophore A23187 on acrosome reaction of tree shrew sperm in vitro: examination of acrosome reaction with an improved fluorescence microscopy. Anim. Reprod. Sci. 1997, 49 (2-3), 225-234.
19. Zheng, Y.; Ben, K. Use of MTT assay for the determination of cell viability and proliferation. Immunol. J. 1992, 8 (4), 266-269 (In Chinese).
20. Fernandez-Botran, R.; Větvička, V. Detection of antibodies. In Methods in Cellular Immunology; CRC Press: Boca Raton, 1995; 177-201.
21. Harrison, R.A.; Lachmann. Complement technology. In Handbook of Experimental Immunology, 4th Ed.; Weir, D.M., Ed.; Blackwell Scientific Publications: Oxford, UK, 1986; Vol. 1, 39.1-39.49.
22. Richardson, J.; Kaushic, C.; Wira, C.R. Estradiol regulation of secretory component: expression by rat uterine epithelial cells. J. Steroid Biochem. Mol. Biol. 1993, 47 (1-6), 143-149.
23. Wang, X.; Sun, L.; Ben, K.; Xu, J.; Cao, X. Purification of human colostrum secretory component, preparation of rabbit anti-human SC sera and its application. Immunol. J. 2002, 18 (5), 381-384 (In Chinese).
24. Bizzarro, A.; Valentini, G.; Martino, D.I.; Daponte, A.; Bellis, A.D.; Iacono, G. Influence of testosterone therapy on clinical and immunological features of autoimmune diseases associated with Klinefelter's syndrome. J. Clin. Endocrinol. Metab. 1987, 64 (1), 32-36.
25. Viselli, S.M.; Reeese, K.R.; Fan, J.; Kovacs, W.J.; Olsen, N.J. Androgens alter B cell development in normal male mice. Cell. Immunol. 1997, 182 (2), 99-104.
26. Ellis, T.M.; Moser, M.T.; Le, P.H.; Flanigan, R.C.; Kwon, E.D. Alterations in peripheral B cells and B cell progenitors following androgen ablation in mice. Int. Immunol. 2001, 13 (4), 553-558.
27. Kocar, I.H.; Yesilova, Z.; Özata, M.; Turan, M.; Sengül, A.; Özdemir, I. The effect of testosterone replacement treatment on immunological features of patients with Klinefelter's syndrome. Clin. Exp. Immunol. 2000, 121 (3), 448-452.
28. Giltay, E.J.; Fonk, J.C.; Von Blomberg, B.M.; Drexhage, H.A.; Schalkwijk, C.; Gooren, L.J. In vivo effects of sex steroids on lymphocyte responsiveness and immunoglobulin levels in humans. J. Clin. Endocrinol. Metab. 2000, 85 (4), 1648-1657.
29. Seaman, W.E.; Blackman, M.A.; Gindhart, T.D.; Roubinian, J.R.; Loeb, J.M.; Talal, N. β-estradiol reduces natural killer cells In Mice. J. Immunol., 1978, 121 (6), 2193-2198.
30. Pöllänen, P.; Saari, T.; Yeung, C.H.; Cooper, T.G. Regulation of the transport immunoglobulin G into the male rat reproductive tract. J. Reprod. Immunol. 1995, 28 (3), 111-135.